Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTOG2: Gemcitabine + Platinum in Advanced NSCLC
NCT00112710Phase 3Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Mar 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, carboplatin in non-small cell lung cancer (NSCLC), sponsored by University Hospitals Birmingham. Status: unknown.
02
Drugs
cisplatincarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00112710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112710.